Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award Chief Commercial Officer acquired 200,000 shares (grant or award)
  3. 4 Planned sale Director sold 2,000 shares at $1.91 ($3,820)
  4. 4 Planned sale Director sold 2,000 shares at $2.69 ($5,380)
  5. 4 Open-market sale Chief Executive Officer sold 1,880 shares at $2.80 ($5,264)
  6. 4 Open-market sale Chief Commercial Officer sold 791 shares at $16.53 ($13,075)
  7. 4/A Open-market sale Chief Commercial Officer sold 1,758 shares at an average $17.04 ($29,951)
  8. 4 Planned sale SVP, China Operations sold 12,500 shares at an average $17.19 ($214,925)
  9. 4 Planned sale Director sold 3,944 shares at an average $17.17 ($67,717)
  10. 4 Planned sale Director sold 4,733 shares at an average $17.19 ($81,367)
  11. 4 Planned sale Director sold 8,520 shares at an average $17.20 ($146,571)
  12. 4 Planned sale Director sold 8,520 shares at an average $17.44 ($148,591)
  13. 4 Grant or award Director acquired 8,289 shares (grant or award)
  14. 4 Planned sale Director sold 7,889 shares at an average $17.19 ($135,622)
  15. 4 Planned sale Director sold 7,000 shares at an average $17.46 ($122,185)
  16. 4 Planned sale Director sold 7,100 shares at $18.03 ($127,987)
  17. 4 Open-market sale Chief Commercial Officer sold 1,758 shares at an average $17.04 ($29,951)
  18. 4 Open-market sale Chief Financial Officer sold 1,785 shares at an average $16.99 ($30,320)
  19. 4 Open-market sale SVP, China Operations sold 3,633 shares at an average $17.04 ($61,894)
  20. 4 Open-market sale EVP, Chief Medical Officer sold 2,042 shares at $17.04 ($34,792)

Page 5 of 38 · 760 filings